Lestaurtinib FLT3 inhibitory activity is modulated by concomitant azole therapy and may Influence relapse risk

Knapper, Steven ORCID: https://orcid.org/0000-0002-6405-4441, Burnett, Alan Kenneth, Hills, Robert Kerrin ORCID: https://orcid.org/0000-0003-0166-0062, Small, Donald and Levis, Mark 2009. Lestaurtinib FLT3 inhibitory activity is modulated by concomitant azole therapy and may Influence relapse risk. Blood -New York- 114 (22) , p. 326.

Full text not available from this repository.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Subjects:	R Medicine > R Medicine (General) R Medicine > RC Internal medicine
Additional Information:	51st Annual Meeting of the American-Society-of-Hematology Location: New Orleans, LA Date: DEC 05-08, 2009
Publisher:	American Society of Hematology
ISSN:	0006-4971
Last Modified:	24 Oct 2022 11:55
URI:	https://orca.cardiff.ac.uk/id/eprint/49758

Citation Data

Actions (repository staff only)

Edit Item